Correction to Lancet Healthy Longev 2022; 3: e589–98

Tang T, Hammel IS, Andrew MK, Ruiz JG. COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort study. Lancet Healthy Longev 2022; 3: e589–98—In this Article, in the Summary Findings, the last sentence should read: “By 30 days of a positive SARS-CoV-2 test, the vaccine effectiveness for all-cause death was 79% (95% CI 74–84) in the robust group, 79% (75–83) in the pre-frail group, and 68% (63–71) in the frail group.” This correction has been made to the online version as of Sept 6, 2022.